Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotideHélène Tran, Robert H. Brown, Nicholas Wightman et al.|Nature Medicine|2021Cited by 173
Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff MiceHannah G. Lahey, Miguel Sena‐Esteves, Chelsea Joy Webber et al.|Molecular Therapy|2020Cited by 36
Quantifying and mitigating motor phenotypes induced by antisense oligonucleotides in the central nervous systemMichael P. Moazami, Jonathan K. Watts, Julia M Rembetsy-Brown et al.|Molecular Therapy|2024Cited by 26
Quantifying and Mitigating Motor Phenotypes Induced by Antisense Oligonucleotides in the Central Nervous SystemMichael P. Moazami, Jonathan K. Watts, Julia M Rembetsy-Brown et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 17
AAV Gene Therapy Strategies for Lysosomal Storage Disorders with Central Nervous System InvolvementDiane Golebiowski, Miguel Sena‐Esteves, Allison M. Bradbury et al.|Neuromethods|2015Cited by 6